updated: November, 2017
The requesting physician and an Infectious Disease Specialist or Respirologist should supply a letter along with the Nova Scotia ordering requisition to AbbVie Corporation (AbbVie) providing medical justification for ordering palivizumab.
Eligible requests will be approved by an Infectious Disease physician at the IWK Health Centre.
If physicians are unsure whether a patient is eligible, the Pediatric Infectious Diseases physician on call at the IWK Health Centre is willing to provide a consult and can be contacted at (902) 470-8888 or a fax can be sent to their attention at (902) 470-7846. Examples of children who could be considered high risk are those with severe combined immunodeficiency syndrome or severe hypotonia preventing adequate clearance of respiratory secretions or those with sever chronic lung disease not due to prematurity.Share
Dalhousie University Health Law and Policy Seminar Series - Guaranteed Income and Health | November 2, 2018
Dalhousie University Health Law and Policy Seminar Series - Of Bricks and Blood: Institutional Conscience Objections to MAID and Abortion | November 23, 2018
Dalhousie University Health Law and Policy Seminar Series - Cannabis Legislation: Past, Present and Future | January 18, 2019